Home › SHAILY › Filing
🔔 Get instant alerts when SHAILY files quarterly results on BSE Start free trial →

Investor Presentation

Filed: 29 Oct 2026, 19:06 IST Exchange: NSE Category: Financial Results — Investor Presentation
Investor Presentation - Q2 & H1 FY27 - Revenue grew 24% in Q2 and 19% in H1 FY27, driven by healthcare segment - EBITDA margin improved by 10 bps in Q2 and 60 bps in H1 FY27 - New product launches include Shaily AI Toby reusable auto-injector for GLP-1 therapies - Capacity expansion: 25 Mn pens added; new Abu Dhabi facility planned with 75 Mn pens capacity - CARE Ratings upgraded short-term bank facilities to A1+; long-term facilities reaffirmed at A+ - Domestic market weak for home furnishings; export share increased due to healthcare growth - RoCE and RoE improved significantly by Sep 2026 - Cash PAT increased 19% in Q2 and H1 FY27
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 SHAILY — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add SHAILY to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Shaily Engineering Plastics Limited

Important. The summary above is generated automatically from Shaily Engineering Plastics Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.